Chott A
Klinisches Institut für Pathologie der Universität Wien, Allgemeines Krankenhaus, Vienna, Austria.
Pathologe. 2003 Feb;24(1):15-27. doi: 10.1007/s00292-002-0594-5. Epub 2003 Jan 21.
Intestinal lymphomas are almost exclusively non-Hodgkin lymphomas (NHL) which occur at a slightly lower frequency than those arising in the stomach. Intestinal NHLs differ from nodal lymphomas because they retain some properties of the mucosa-associated lymphoid tissue (MALT) from which they arise. The recently proposed WHO classification of lymphoid neoplasias encompasses and defines all the NHLs occurring in the gastrointestinal tract as lymphoma entities. The histopathological diagnosis relies on the combination of morphology and immunohistochemistry, which represents the gold standard. By this means a correct diagnosis can be achieved in the vast majority of cases. If nevertheless diagnostic problems arise, they can usually be managed by a re-biopsy, or in individual cases by molecular studies. At any rate, the pathologist must classify the lymphoma according to the WHO classification and diagnoses such as "low-grade B-cell lymphoma" or "small B-cell lymphoma" are not acceptable.
肠道淋巴瘤几乎均为非霍奇金淋巴瘤(NHL),其发病频率略低于胃部淋巴瘤。肠道NHL与淋巴结淋巴瘤不同,因为它们保留了起源的黏膜相关淋巴组织(MALT)的一些特性。最近提出的世界卫生组织(WHO)淋巴样肿瘤分类涵盖并将所有发生在胃肠道的NHL定义为淋巴瘤实体。组织病理学诊断依赖于形态学和免疫组织化学的结合,这是金标准。通过这种方法,绝大多数病例都能实现正确诊断。然而,如果出现诊断问题,通常可通过再次活检解决,个别情况下可通过分子研究解决。无论如何,病理学家必须根据WHO分类对淋巴瘤进行分类,诸如“低级B细胞淋巴瘤”或“小B细胞淋巴瘤”等诊断是不可接受的。